Pediatric intracranial neoplasms require delicate clinical management because aggressive interventions can disrupt growing central nervous tissues. Consequently, clinicians increasingly explore targeted modalities to minimize surgical morbidity. A recent seminal study evaluated the role of pediatric Gamma Knife radiosurgery across patients with sporadic lesions and syndromic conditions. Stereotactic radiosurgery delivers focused ionizing beams to precise anatomical targets while sparing adjacent delicate structures. Although historical data in children remain relatively scarce, emerging clinical evidence highlights its utility for managing benign skull base lesions. Therefore, neurosurgeons now consider radiosurgical intervention an essential component of multidisciplinary pediatric oncology care.

Clinical Challenges in Pediatric Meningiomas and Schwannomas

Pediatric meningiomas and schwannomas display distinct biological and clinical behaviors compared to their adult counterparts. Although relatively uncommon in children, these intracranial neoplasms often present with aggressive growth trajectories and complex anatomical configurations. Furthermore, skull base locations frequently involve critical neurovascular structures, such as cranial nerves and major cerebral arteries. Consequently, complete surgical resection poses substantial risks, including persistent cranial nerve deficits, cerebrospinal fluid leaks, and ischemic injury. In addition, younger patients must endure decades of potential tumor recurrence or treatment-related complications.

When these tumors develop alongside hereditary conditions, clinical management becomes considerably more challenging. Patients with neurofibromatosis type 2 (NF2) carry germline alterations in the NF2 tumor suppressor gene. Because of this genetic defect, patients develop multiple intracranial neoplasms, primarily bilateral vestibular schwannomas and multiple meningiomas. Repeated microsurgical resections in such patients compound functional neurological morbidity and accelerate hearing deterioration. Therefore, radiation oncologists and neurosurgeons actively seek non-invasive therapeutic alternatives that preserve long-term quality of life. Stereotactic platforms deliver highly conformal radiation, limiting collateral damage to adjacent brain parenchyma and functional neural pathways. By adopting tailored radiosurgical protocols, clinical teams aim to arrest tumor growth while preserving vital neurological and sensory functions throughout childhood.

Study Design and Radiosurgical Parameters

To evaluate radiosurgical efficacy in youth, researchers conducted a comprehensive retrospective cohort study. The investigation evaluated patients aged 18 years or younger who underwent Gamma Knife treatment between January 2013 and December 2021. In total, the authors examined twenty-six pediatric patients who collectively harbored forty distinct intracranial neoplasms. Among the cohort, thirteen individuals had a confirmed clinical or genetic diagnosis of neurofibromatosis type 2. The mean age at the time of stereotactic treatment was 15.4 years, reflecting a predominantly adolescent patient population.

Histologically, schwannomas constituted seventy-five percent of the treated intracranial lesions, whereas meningiomas accounted for twenty-five percent. Clinicians delivered a mean prescription dose of 12.8 Gy to tumor margins, aligning closely with standard adult skull base radiosurgery guidelines. The radiation physicists and neurosurgeons meticulously planned each dose to maximize conformality and steepen dose gradients. Furthermore, the clinical teams systematically tracked radiological changes using serial high-resolution magnetic resonance imaging over an average follow-up period of 51 months. This extended follow-up window permitted an in-depth assessment of long-term local tumor control, volumetric adjustments, and late radiation-induced complications. Through this robust design, the study established objective volumetric metrics to compare syndromic lesions directly against sporadic counterparts.

Tumor Control and Volumetric Regression Dynamics

The investigation demonstrated remarkable overall tumor control across the entire pediatric patient series. After a mean follow-up period of over four years, all forty intracranial lesions either regressed or maintained radiological stability. Thus, the primary radiosurgical intervention achieved a hundred percent overall disease control rate during this surveillance period. Such profound stability confirms that stereotactic beams effectively halt the proliferative drive of pediatric schwannomas and meningiomas. Moreover, the findings demonstrate that radiosurgery achieves local control rates comparable to extensive surgical resection without exposing children to open craniotomy risks.

Nevertheless, quantitative volumetric measurements revealed significant differences in the degree of tumor regression. Overall, non-syndromic lesions shrank far more consistently and substantially than syndromic counterparts. Specifically, all sporadic tumors exhibited measurable size reduction, whereas regression occurred in approximately sixty-nine percent of NF2-associated lesions. Furthermore, sporadic neoplasms displayed a median volumetric reduction of 21.7 percent compared to only 10.5 percent among syndromic lesions. This difference reached high statistical significance, emphasizing that sporadic tumors undergo more pronounced post-radiation shrinkage. However, clinician teams must recognize that radiographic tumor arrest remains the ultimate therapeutic benchmark. Even when a treated tumor does not visibly shrink, halting progression prevents severe neurological deficits and postpones aggressive surgical interventions.

Impact of Neurofibromatosis Type 2 on Treatment Responses

The presence of underlying neurofibromatosis type 2 clearly altered tumor biology and radiosurgical responsiveness. While sporadic neoplasms universally regressed, syndromic lesions exhibited greater resistance to radiation-induced cytoreduction. Molecular biologists believe that underlying germline mutations in the merlin protein influence cellular apoptosis, vascular endothelial growth, and tissue remodeling after radiation. Consequently, NF2-associated schwannomas and meningiomas often display intrinsic biological resilience against ionizing radiation. In addition, syndromic patients frequently develop multiple adjacent lesions, complicating volumetric assessment and long-term surveillance.

Despite these lower regression rates, Gamma Knife treatment achieved disease stabilization in all syndromic tumors within the study cohort. Therefore, clinicians should view radiosurgery as a valuable tool for NF2 patients, rather than dismissing it due to modest volumetric shrinkage. Furthermore, delaying open microsurgical interventions protects vulnerable cranial nerves, particularly the vestibulocochlear and facial nerve complexes. In young patients who face lifelong tumor development, radiosurgical stabilization provides vital symptom-free intervals and spares hearing function. Neurologists and neurosurgeons should nevertheless monitor syndromic cohorts closely using regular magnetic resonance imaging. Because syndromic lesions occasionally show delayed regrowth after initial stabilization, structured long-term imaging protocols remain indispensable. Combining radiosurgery with targeted biological agents may eventually optimize local cytoreduction in this challenging genetic population.

Safety Profiles and Future Outlook for Pediatric Gamma Knife Radiosurgery

A vital finding of this pediatric investigation centers on the remarkable safety profile of stereotactic radiation. The treatment produced exceptionally low rates of acute and delayed adverse radiation effects. During the four-year follow-up window, children did not experience severe radiation necrosis, secondary malignancies, or symptomatic peritumoral edema. Consequently, pediatric Gamma Knife radiosurgery proved to be a secure therapeutic modality for deep-seated intracranial tumors. The steep dose gradient characteristic of Gamma Knife systems successfully shielded sensitive developing neural structures from harmful bystander radiation doses.

Looking toward the future, clinicians must integrate these findings into comprehensive neuro-oncology treatment pathways. Multidisciplinary tumor boards should actively consider radiosurgery for growing pediatric skull base tumors before neurological deficits manifest. However, neurosurgeons must exercise caution regarding cumulative radiation exposure, especially when syndromic patients require repeated radiosurgical sessions. Modern stereotactic platforms now offer fractionated or hypofractionated options, which may enhance therapeutic margins for larger lesions. Furthermore, ongoing translational research into targeted molecular inhibitors, such as MEK inhibitors and vascular endothelial growth factor antagonists, could synergize with radiosurgery. By pairing precision radiation with modern molecular therapies, clinicians will continue to refine management strategies, minimize morbidity, and significantly improve quality of life for young patients.

What is the primary advantage of Gamma Knife radiosurgery in pediatric skull base tumors?

Gamma Knife radiosurgery delivers highly focused, conformally targeted radiation to intracranial neoplasms while sparing adjacent healthy brain tissue. Consequently, it achieves durable tumor stabilization without the substantial risks of open craniotomy, including permanent cranial nerve deficits, cerebrospinal fluid leakage, hemorrhage, and lengthy postoperative hospital recovery in vulnerable pediatric patients.

Why do NF2-associated tumors exhibit lower regression rates after radiosurgery than sporadic tumors?

NF2-associated tumors harbor biallelic mutations in the NF2 tumor suppressor gene, which alters cellular apoptosis and vascular signaling pathways. Consequently, these genetic abnormalities confer intrinsic biological resilience against radiation damage. Therefore, syndromic schwannomas and meningiomas exhibit slower volumetric shrinkage, although radiosurgery still successfully halts ongoing disease progression and maintains radiological stability.

What follow-up protocols are recommended for children receiving stereotactic radiosurgery?

Clinicians recommend lifelong surveillance with high-resolution magnetic resonance imaging for pediatric patients undergoing stereotactic radiosurgery. Surveillance scans should occur every six to twelve months initially, transitioning to annual evaluations. This vigilant monitoring detects delayed tumor recurrence, pseudoprogression, radiation necrosis, or newly emerging neoplasms, which are particularly common in patients with neurofibromatosis type 2.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Refer to the latest local and national guidelines for clinical practice.

References

Goyal-Honavar A et al. Gamma Knife radiosurgery in a cohort of neurofibromatosis type 2-associated and sporadic pediatric meningiomas and schwannomas. J Neurosurg Pediatr. 2025 Jul 01. doi: 10.3171/2025.1.PEDS24308. PMID: 40215625.

Graffeo CS, et al. Gamma Knife stereotactic radiosurgery for pediatric meningiomas. Stereotact Funct Neurosurg. 2026;104(2):112-120.

Sheehan JP, et al. Skull base meningiomas in patients with neurofibromatosis type 2: An international multicenter study evaluating stereotactic radiosurgery. J Neurol Surg B Skull Base. 2021;82(6):621-628.